Aldehyde dehydrogenase 1A3 is transcriptionally activated by all-trans-retinoic acid in human epidermal keratinocytes

Biochemical and Biophysical Research Communications

Volumn 400, Issue 2, 2010, Pages 207-211

  Koenig, Ulrich ^a   Amatschek, Stefan ^a   Mildner, Michael ^a   Eckhart, Leopold ^a   Tschachler, Erwin ^a,b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b Centre de Recherches et d'Investigations Epidermiques et Sensorielles CERIES   (France)

Author keywords

Aldehyde dehydrogenase; ALDH1A3; Keratinocytes; Retinoic acid; Skin equivalents

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A1; ALDEHYDE DEHYDROGENASE 1A2; ALDEHYDE DEHYDROGENASE 1A3; ALDEHYDE DEHYDROGENASE 1B1; ALDEHYDE DEHYDROGENASE 3A2; ALDEHYDE DEHYDROGENASE ISOENZYME 2; MESSENGER RNA; RETINOIC ACID; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG METABOLISM; EPIDERMIS CELL; EXPLANT; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CULTURE; TRANSCRIPTION INITIATION; UPREGULATION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; EPIDERMIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ALDEHYDE DEHYDROGENASE; CELLS, CULTURED; EPIDERMIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KERATINOCYTES; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRETINOIN;

EID: 77956754088     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.035     Document Type: Article

References (21)

1. Bhat P.V., Poissant L., Falardeau P., Lacroix A. Enzymatic oxidation of all-trans-retinal to retinoic acid in rat tissues. Biochem. Cell Biol. 1988, 66:735-740.
2. Black W.J., Stagos D., Marchitti S.A., Nebert D.W., Tipton K.F., Bairoch A., Vasiliou V. Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature. Pharmacogenet. Genomics 2009, 19:893-902.
3. Dupe V., Matt N., Garnier J.M., Chambon P., Mark M., Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. USA 2003, 100:14036-14041.
4. Eckhart L., Schmidt M., Mildner M., Mlitz V., Abtin A., Ballaun C., Fischer H., Mrass P., Tschachler E. Histidase expression in human epidermal keratinocytes: regulation by differentiation status and all-trans-retinoic acid. J. Dermatol. Sci. 2008, 50:209-215.
5. Everts H.B., King L.E., Sundberg J.P., Ong D.E. Hair cycle-specific immunolocalization of retinoic acid synthesizing enzymes Aldh1a2 and Aldh1a3 indicate complex regulation. J. Invest. Dermatol. 2004, 123:258-263.
6. Everts H.B., Sundberg J.P., King L.E., Ong D.E. Immunolocalization of enzymes, binding proteins, and receptors sufficient for retinoic acid synthesis and signaling during the hair cycle. J. Invest. Dermatol. 2007, 127:1593-1604.
7. Fisher G.J., Voorhees J.J. Molecular mechanisms of retinoid actions in skin. FASEB J. 1996, 10:1002-1013.
8. Hodam J.R., Creek K.E. Comparison of the metabolism of retinol delivered to human keratinocytes either bound to serum retinol-binding protein or added directly to the culture medium. Exp. Cell Res. 1998, 238:257-264.
9. Kang S., Li X.Y., Voorhees J.J. Pharmacology and molecular action of retinoids and vitamin D in skin. J. Invest. Dermatol. Symp. Proc. 1996, 1:15-21.
10. Marchitti S.A., Brocker C., Stagos D., Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 2008, 4:697-720.
11. Montplaisir V., Lan N.C., Guimond J., Savineau C., Bhat P.V., Mader S. Recombinant class I aldehyde dehydrogenases specific for all-trans- or 9-cis-retinal. J. Biol. Chem. 2002, 277:17486-17492.
12. Mrass P., Rendl M., Mildner M., Gruber F., Lengauer B., Ballaun C., Eckhart L., Tschachler E. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res. 2004, 64:6542-6548.
13. Orfanos C.E., Zouboulis C.C., Almond-Roesler B., Geilen C.C. Current use and future potential role of retinoids in dermatology. Drugs 1997, 53:358-388.
14. Rendl M., Ban J., Mrass P., Mayer C., Lengauer B., Eckhart L., Declerq W., Tschachler E. Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. J. Invest. Dermatol. 2002, 119:1150-1155.
15. Saurat J.H., Didierjean L., Masgrau E., Piletta P.A., Jaconi S., Chatellard-Gruaz D., Gumowski D., Masouye I., Salomon D., Siegenthaler G. Topical retinaldehyde on human skin: biologic effects and tolerance. J. Invest. Dermatol. 1994, 103:770-774.
16. Sima A., Parisotto M., Mader S., Bhat P.V. Kinetic characterization of recombinant mouse retinal dehydrogenase types 3 and 4 for retinal substrates. Biochim. Biophys. Acta 2009, 1790:1660-1664.
17. Staab C.A., Ceder R., Roberg K., Grafstrom R.C., Hoog J.O. Serum-responsive expression of carbonyl-metabolizing enzymes in normal and transformed human buccal keratinocytes. Cell Mol. Life Sci. 2008, 65:3653-3663.
18. Stark H.J., Baur M., Breitkreutz D., Mirancea N., Fusenig N.E. Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiation. J. Invest. Dermatol. 1999, 112:681-691.
19. Taimi M., Helvig C., Wisniewski J., Ramshaw H., White J., Amad M., Korczak B., Petkovich M. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J. Biol. Chem. 2004, 279:77-85.
20. Tschachler E., Reinisch C.M., Mayer C., Paiha K., Lassmann H., Weninger W. Sheet preparations expose the dermal nerve plexus of human skin and render the dermal nerve end organ accessible to extensive analysis. J. Invest. Dermatol. 2004, 122:177-182.
21. Weninger W., Uthman A., Pammer J., Pichler A., Ballaun C., Lang I.M., Plettenberg A., Bankl H.C., Sturzl M., Tschachler E. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab. Invest. 1996, 75:647-657.